| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 62,819 | 68,182 | 70,952 | 75,228 | | Cost of Revenue | 130,281 | 35,789 | 36,227 | 36,558 | | | Gross Profit | (67,462) | 32,393 | 34,725 | 38,670 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,547 | 11,553 | 16,856 | 15,151 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 495 | 484 | 483 | 502 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,692 | 20,356 | 17,386 | 23,017 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 114 | 124 | 137 | (502) | | Earnings Before Interest And Taxes | 14,806 | 20,480 | 17,523 | 22,515 | | Interest Expense | 24,998 | 25,802 | 24,974 | 24,295 | | Income Before Tax | (10,192) | (5,322) | (7,451) | (1,780) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,192) | (5,322) | (7,451) | (1,780) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 3,064 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,192) | (5,322) | (7,451) | 1,284 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,192) | ($5,322) | ($7,451) | $1,284 |
|
0.22% Nasdaq 0.00%
Income Statement
